Induction of cell cycle arrest via the p21, p27–cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol

1. L. Cahoon, The curious case of clioquinol, Nat. Med. 15 (2009) 356-359; DOI: 10.1038/nm0409-356.10.1038/nm0409-356Search in Google Scholar

2. J. Tateishi, Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals, Neuropathology 20 (2000) S20-S24; DOI: 10.1046/j.1440-1789.2000.00296.x.10.1046/j.1440-1789.2000.00296.xSearch in Google Scholar

3. T. Tsubaki, Y. Honma and M. Hoshi, Neurological syndrome associated with clioquinol, Lancet 1 (1971) 696-697.10.1016/S0140-6736(71)92699-7Search in Google Scholar

4. L. Helmuth, Neuroscience. An antibiotic to treat Alzheimer’s? Science 290 (2000) 1273-1274; DOI: 10.1126/science.290.5495.1273a.10.1126/science.290.5495.1273aSearch in Google Scholar

5. X. Mao and A. D. Schimmer, The toxicology of clioquinol, Toxicol. Lett. 182 (2008) 1-6; DOI: 10.1016/j.toxlet.2008.08.015.10.1016/j.toxlet.2008.08.015Search in Google Scholar

6. M. H. Park, S. J. Lee, H. R. Byun, Y. Kim, Y. J. Oh, J. Y. Koh and J. J. Hwang, Clioquinol induces autophagy in cultured astrocytes and neurons by acting as a zinc ionophore, Neurobiol. Dis. 42 (2011) 242-251; DOI: 10.1016/j.nbd.2011.01.009.10.1016/j.nbd.2011.01.009Search in Google Scholar

7. S. R. Bareggi and U. Cornelli, Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders, CNS Neurosci. Ther. 18 (2012) 41-46; DOI: 10.1111/j.1755-5949.2010. 00231.x.Search in Google Scholar

8. K. G. Daniel, D. Chen, S. Orlu, Q. C. Cui, F. R. Miller and Q. P. Dou, Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteosome inhibitors and apoptosis inducers in human breast cancer cells, Breast Cancer Res. 7 (2005) 897-908; DOI: 10.1186/bcr1322.10.1186/bcr1322Search in Google Scholar

9. T. Du, G. Filiz, A. Caragounis, P. J. Crouch and A. R. White, Clioquinol promotes cancer cell toxicity through tumor necrosis factor alpha release from macrophages, J. Pharmacol. Exp. Ther. 324 (2008) 360-367; DOI: 10.1124/jpet.107.130377.10.1124/jpet.107.130377Search in Google Scholar

10. M. W. Lee, P. C. Lin and W. C. Tsai, The anti-cancer effects of clioquinol on oral cancer, EACR-23 Poster Sessions/Eur. J. Cancer 50 (2014) S42.10.1016/S0959-8049(14)50159-1Search in Google Scholar

11. O. Afzal, S. Kumar, M. R. Haider, M. R. Ali, R. Kumar, M. Jaggi and S. Baw, A review on anticancer potential of bioactive heterocycle quinolone, Eur. J. Med. Chem. 97 (2015) 871-910; DOI: 10.1016/j. ejmech.2014.07.044.Search in Google Scholar

12. W . Q. Ding, B. Liu, J. L. Vaught, H. Yamauchi and S. E. Lind, Anti-cancer activity of the antibiotic clioquinol, Cancer Res. 65 (2005) 3389-3395; DOI: 10.1158/0008-5472.CAN-04 -3577.Search in Google Scholar

13. X. Mao, X. Li, R. Sprangers, X. Wang, A. Venugopal, T. Wood, Y. Zhang, D. A. Kuntz, E. Coe, S. Trudel, D. Rose, R. A. Batey, L. E. Kay and A. D. Schimmer, Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma, Leukemia 23 (2009) 585-590; DOI: 10.1038/leu.2008.232.10.1038/leu.2008.23218754030Search in Google Scholar

14. A. D. Schimmer, Y. Jitkova, M. Gronda, Z. Wang, J. Brandwein, C. Chen, V. Gupta, A. Schuh, K. Yee, J. Chen, S. Ackloo, T. Booth, S. Keays and M. D. Minden, A Phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignancies, Clin. Lymphoma Myeloma Leuk. 12 (2012) 330-336; DOI: 10.1016/j.clml.2012.05.005.10.1016/j.clml.2012.05.00522683301Search in Google Scholar

15. T. Kanzawa, Y. Kondo, H. Ito, S. Kondo and I. Germano, Induction of autophagic cell death in malignant glioma cells by arsenic trioxide, Cancer Res. 63 (2003) 2103-2108.Search in Google Scholar

16. K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2-delta delta CT method, Methods 52 (2001) 402-408; DOI: 10.1006/ meth.2001.1262.10.1006/meth.2001.126211846609Search in Google Scholar

17. H. Yu, Y. Zhou, S. E. Lind and W. Q. Ding, Clioquinol targets zinc to lysosomes in human cancer cells, Biochem. J. 417 (2009) 133-139; DOI: 10.1042/BJ20081421.10.1042/BJ2008142118764784Search in Google Scholar

18. H. Yu, J. R. Lou and W. Q. Ding, Clioquinol independently targets NF kappa B and lysosome pathways in human cancer cells, Anticancer Res. 30 (2010) 2087-2092.Search in Google Scholar

19. D. Chen, Q. C. Cui, H. Yang, R. A. Barrea, F. H. Sarkar, S. Sheng, B. Yan, G. P. Reddy and Q. P. Dou, Clioquinol, a therapeutic agent for Alzheimer’s disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts, Cancer Res. 67 (2007) 1636-1644; DOI: 10.1158/0008-5472. CAN -06-3546.Search in Google Scholar

20. M. A. Cater and Y. Haupt, Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer, Biochem. J. 436 (2011) 481-491; DOI: 10.1042/BJ20110123.10.1042/BJ2011012321426304Search in Google Scholar

21. M. Katsuyama, K. Iwata, M. Ibi, K. Matsunob, M. Matsumotob and C. Yabe-Nishimura, Clioquinol induces DNA double-strand breaks, activation of ATM, and subsequent activation of p53 signaling, Toxicology 299 (2012) 55-59; DOI: 10.1016/j.tox.2012.05.013.10.1016/j.tox.2012.05.01322627294Search in Google Scholar

22. C. Laezza, S. Pisanti, E. Crescenzi and M. Bifulco, Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells, FEBS Lett. 580 (2006) 6076-6082; DOI:10.1016/j.febslet.2006.09.074.10.1016/j.febslet.2006.09.07417055492Search in Google Scholar

23. E. J. Yeo, J. H. Ryu, Y. S. Chun, Y. S. Cho, I. J. Jang, H. Cho, J. Kim, M. S. Kim and J. W. Park, YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases, Cancer Res. 66 (2006) 6345-6352; DOI: 10.1158/0008-5472.CAN-05-4460. 10.1158/0008-5472.CAN-05-446016778212Search in Google Scholar